Acceptability of early antiretroviral therapy among South African women.

Garrett N, Norman E, Leask K, Naicker N, Asari V, Majola N, Abdool Karim Q, and Abdool Karim SS.
AIDS and Behavior 2018; 22(3):1018-1024.

Read publication
Longitudinal trends in the prevalence of detectable HIV viremia: Population-based evidence from rural KwaZulu-Natal, South Africa.

Vandormael A, Bärnighausen T, Herbeck J, Tomita A, Phillips A, Pillay D, de Oliveira T, Tanser F.
Clinical Infectious Diseases 2018; 66(8):1254-1260.

Read publication
Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa.

Dawood H, Hassan-Moosa R, Yende-Zuma N, Naidoo K.
BMC Infectious Diseases 2018; 18(1):168. doi: 10.1186/s12879-018-3083-z.

Read publication
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.

Richardson SI, Chung AW, Natarajan H, Mabvakure B, Mkhize NN, Garrett N, Abdool Karim SS, Moore PL, Ackerman ME, Alter G, Morris L.
PLoS Pathogens 2018; 14(4): e1006987. doi: 10.1371/journal.ppat.1006987.

Read publication
Exploratory analysis of the ecological variables associated with sexual health profiles in high-risk, sexually-active female learners in rural KwaZulu-Natal.

Humphries H, Osman F, Knight L, Abdool Karim Q.
PLoS One 2018; 13(4): e0195107. doi: 10.1371/journal.pone.0195107

Read publication
Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015.

Smith CM, Lessells R, Grant AD, Herbst K, Tanser F.
International Union against Tuberculosis and Lung Disease 2018; 22(3):287-293.

Read publication

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.